Vivos Therapeutics (VVOS) Non-Current Assets (2019 - 2025)
Historic Non-Current Assets for Vivos Therapeutics (VVOS) over the last 7 years, with Q3 2025 value amounting to $19.9 million.
- Vivos Therapeutics' Non-Current Assets rose 14984.9% to $19.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $54.6 million, marking a year-over-year increase of 6866.36%. This contributed to the annual value of $7.8 million for FY2024, which is 553.88% down from last year.
- Latest data reveals that Vivos Therapeutics reported Non-Current Assets of $19.9 million as of Q3 2025, which was up 14984.9% from $19.3 million recorded in Q2 2025.
- In the past 5 years, Vivos Therapeutics' Non-Current Assets registered a high of $19.9 million during Q3 2025, and its lowest value of $5.2 million during Q1 2021.
- For the 5-year period, Vivos Therapeutics' Non-Current Assets averaged around $9.0 million, with its median value being $8.2 million (2024).
- Examining YoY changes over the last 5 years, Vivos Therapeutics' Non-Current Assets showed a top increase of 14984.9% in 2025 and a maximum decrease of 632.25% in 2025.
- Vivos Therapeutics' Non-Current Assets (Quarter) stood at $6.4 million in 2021, then surged by 30.34% to $8.3 million in 2022, then fell by 0.33% to $8.3 million in 2023, then dropped by 5.54% to $7.8 million in 2024, then surged by 154.23% to $19.9 million in 2025.
- Its Non-Current Assets was $19.9 million in Q3 2025, compared to $19.3 million in Q2 2025 and $7.7 million in Q1 2025.